Younger for Longer: Insulin Signalling, Immunity and Ageing
Journal:
Current Aging Science
Volume:
3
Page:
166-176
Author(s):
Francis R.G. Amrit and Robin C. May
Optimizing Tumor-Reactive γδT Cells for Antibody-Based Cancer Immunotherapy
Journal:
Current Molecular Medicine
Volume:
10
Page:
719-726
Author(s):
S. Meraviglia, N. Caccamo, G. Guggino, M. Tolomeo, S. Siragusa, G. Stassi and F. Dieli
Is Src a Viable Target for Treating Solid Tumours?
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
683-694
Author(s):
B. Elsberger, B. Stewart, O. Tatarov and J. Edwards
Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
716-727
Author(s):
R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke and K.-A. Kreuzer
DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
758-771
Author(s):
K. Chikamori, A. G. Grozav, T. Kozuki, D. Grabowski, R. Ganapathi and M. K. Ganapathi
Hematological Targets of Radiation Damage
Journal:
Current Drug Targets
Volume:
11
Page:
1375-1385
Author(s):
Shilpa Kulkarni, Sanchita P. Ghosh, Martin Hauer-Jensen and K. Sree Kumar
Histone Deacetylase Inhibitors: New Promise in the Treatment of Immune and Inflammatory Diseases
Journal:
Current Drug Targets
Volume:
11
Page:
1430-1438
Author(s):
Stephen J. Shuttleworth, Sarah G. Bailey and Paul A. Townsend
Irinotecan for Treatment of Childhood Cancers: A Promising Therapeutic Partner
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
283-293
Author(s):
Lars Wagner
Nuclear Receptor SHP as a Potential Therapeutic Target for Liver Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
317-322
Author(s):
Jenny Hatch, Shiguo Liu, Timothy Gayowski, John Sorensen and Li Wang
Copper Compounds in Cancer Chemotherapy
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
3606-3615
Author(s):
L. Ruiz-Azuara and M. E. Bravo-Gomez